Market Cap: $67.67M
CI
Cardiff Oncology, Inc.
CRDF
NASDAQUSD
Market Cap: $67.67M
Cardiff Oncology Inc (Ticker: CRDF) navigates a critical legal landscape as it announces the initiation of legal proceedings against Nerviano Medical Sciences. This significant action arises from Nerv…
Cardiff Oncology Advances Cancer Treatment Amid Market Challenges Cardiff Oncology Inc. (CRDF) is making strides in the fight against metastatic colorectal cancer (mCRC) with its ongoing CRDF-004 Phas…
Cardiff Oncology Advances in Metastatic Colorectal Cancer Research Cardiff Oncology, Inc. (CRDF) is making significant strides in the field of cancer treatment, particularly with its recent developmen…
Cardiff Oncology's Innovative Approach to Metastatic Colorectal Cancer Treatment Cardiff Oncology, Inc. (CRDF) stands at the forefront of advancements in cancer treatment, particularly focusing on met…
Cardiff Oncology Expands Clinical Trials for Oncological Therapeutics Cardiff Oncology, a clinical-stage biotechnology company specializing in innovative cancer therapies, announces significant advanc…
Cardiff Oncology Advances Innovative Cancer Treatment with Promising Clinical Results Cardiff Oncology, a biotechnology company focused on developing targeted therapies for cancer treatment, announces…